Liptruzet: A combination of ezetimibe and atorvastatin

Medical Letter on Drugs and Therapeutics

Volumn 55, Issue 1419, 2013, Pages 49-50

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; LIPTRUZET; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; UNCLASSIFIED DRUG;

CLINICAL TRIAL (TOPIC); DIARRHEA; DRUG APPROVAL; DRUG COST; FAMILIAL HYPERCHOLESTEROLEMIA; FOOD AND DRUG ADMINISTRATION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MYOPATHY; RHABDOMYOLYSIS; SIDE EFFECT;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; DRUG COMBINATIONS; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; PYRROLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84879303371     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Drugs for lipids. Treat Guidel Med Lett 2011; 9:13.
2. CM Ballantyne et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 2003; 107:2409.
3. E Stein et al. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J 2004; 148:447.
4. SE Conard et al. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease. Am J Cardiol 2008; 102:1489.
5. LA Leiter et al. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease. Am J Cardiol 2008; 102:1495.
6. New simvastatin dosing recommendations. Med Lett Drugs Ther 2011; 53:61.